Jul. 10, 2019
EU-OPENSCREEN has proudly published its first activity and financial report for 2018. The report gives an excellent overview of EU-OPENSCREEN´s achievements in the founding year of 2018.
Jul. 3, 2019
Avi Raveh, Chief Scientific Officer, Edward Pichinuk, Head of HTS and Biological Assays Unit and Hamutal Engel, Head of the Computer Aided Drug Design Unit, from BLAVATNIK CENTER for Drug Discovery at...
Jun. 1, 2019
Use EU-OPENSCREEN ERIC’s recently funded EU-OPENSCREEN-DRIVE project to advance your research now. As part of EU-OPENSCREEN-DRIVE we will fund up to 12 small molecule screening projects at...
May. 7, 2019
We are happy to welcome Federica Rossella as Compound Quality Technician and Kathy Skopelitou as Administrative Project Manager as new employees at EU-OPENSCREEN.
May. 3, 2019
Under this call the EU-OPENSCREEN-DRIVE project, funded under the European Union´s research and innovation programme Horizon 2020, will provide researchers with access to cutting-edge European...
Apr. 5, 2019
During the ECBS 2019 in Madrid, Spain, scientists from the field of chemical biology highlighted recent discoveries in screening and drug discovery, systems biology and therapeutic innovation.
Mar. 22, 2019
The development and operation agreement for the open-access European Chemical Biology Database (ECBD) has been signed on March 25 by the Institute of Molecular Genetics (IMG) and the EU-OPENSCREEN...
Mar. 21, 2019
You would like to learn more about EU-OPENSCREEN ERIC operations? Check out our European relations and Grant officer (Katja)'s talk at the University of Cambridge!
Feb. 26, 2019
EU-OPENSCREEN DRIVE will ensure the long-term sustainability of excellence in chemical biology within Europe and beyond.
The ERA-Net on cardiovascular diseases (ERA-CVD) and the European Joint Programme on Rare Diseases (EJP RD) have announced calls for proposals.
Page 1 of 5.